Research Article
Clinical Characteristics and Early Interventional Responses in Patients with Severe COVID-19 Pneumonia
Table 2
Laboratory findings of patients infected with COVID-19.
| | Blood routine | Patients () |
| | Leucocytes (×109 per L; normal range 3.5–9.5) | 6 (4.3-7.6) | | Increased | 5 (14%) | | Decreased | 2 (5%) | | Neutrophils (×109 per L; normal range 1.8–6.3) | 4.5 (2.7-6.6) | | Increased | 9 (24%) | | Lymphocytes (×109 per L; normal range 1.1–3.2) | 0.8 (0.6-1.0) | | Decreased | 28 (76%) | | Platelets (×109 per L; normal range 125.0–350.0) | 200 (141-258) | | Increased | 1 (3%) | | Decreased | 7 (19%) | | Coagulation function | | Activated partial thromboplastin time (normal range 23.5–36.0) | 30.2 (28.1-32.7) | | Increased | 1 (3%) | | Decreased | 0 (0%) | | Prothrombin time (s; normal range 12.5–14.0) | 11.9 (11.3-12.5) | | Increased | 2 (5%) | | Decreased | 28 (76%) | | D-dimer (μg/L; normal range 0.0–0.55) | 0.32 (0.22-0.71) | | Increased | 9 (24%) | | Blood biochemistry | | Alanine aminotransferase (U/L; normal range 9.0–50.0) ALT | 22 (16.5-36) | | Increased | 7 (19%) | | Aspartate aminotransferase (U/L; normal range 15.0–40.0) AST | 28 (21.5-39.5) | | Increased | 9 (24%) | | Serum creatinine (μmol/L; normal range 62.0–97.0) | 42 (29.5-54.5) | | Increased | 5 (14%) | | Creatine kinase (U/L; normal range 38.0–174.0) | 88 (66.5-161.5) | | Increased | 8 (22%) | | Troponin(ng/mL; normal range 0.00-0.08) | 0.01 (0.01) | | Increased | 0 (0%) | | Infection-related biomarkers | | C-reactive protein (mg/L; normal range 0.0–5.0) | 19.1 (10.0-50.8) | | Increased | 32 (86%) | | Erythrocyte sedimentation rate (mm/h; normal range 0.0–20.0) | 42 (29.5-54.5) | | Increased | 31 (84%) | | Procalcitonin (ng/mL; normal range 0.0–0.05) | 0.05 (0.03-0.07) | | Increased | 14 (38%) | | Interleukin-6 (pg/mL; normal range 0.1–2.9) | 12.85 (6.3-27.7) | | Increased | 35 (95%) | | Interleukin-10 (pg/mL; normal range 0.1–5.0) | 5.1 (3.4-9.2) | | Increased | 19 (51%) |
|
|
